Home/Filings/4/0001628280-24-020740
4//SEC Filing

Nark Ted C 4

Accession 0001628280-24-020740

CIK 0001723128other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:34 PM ET

Size

5.5 KB

Accession

0001628280-24-020740

Insider Transaction Report

Form 4
Period: 2024-05-02
Nark Ted C
Director
Transactions
  • Award

    Restricted Stock Units

    2024-05-02+40,25840,258 total
    Class A Common Stock (40,258 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001316851

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:34 PM ET
Size
5.5 KB